Europe — EMA

Ondansetrom Basi (Ondansetron)

...

Request sourcing

Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Ondansetrom Basi, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetrom Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron acts on the serotonergic pathway to prevent the onset of vomiting and nausea in several clinical situations. - Chemotherapy‑induced nausea and vomiting (CINV): It ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .... - Radiotherapy or the ... .... .... .... ... .... ... ... … .

What are the side effects of Ondansetron?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →